Last checked at 17 Sep 2012 09:00
For immediate release | 17 September 2012 |
Futura Medical plc
("Futura" or "the Company")
Grant of Options
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that today it granted options over a total of 550,000 ordinary shares of 0.2p each in the Company to Directors as detailed below.
Director | Number of options granted | Exercise price | Exercise period | Total number of options held following notification | Total number of ordinary shares held |
J H Barder | 250,000 | 61.50p | 1 Oct 2014 - 30 Sep 2019 | 750,000 | 975,330 |
D B Davies | 200,000 | 61.50p | 1 Oct 2014 - 30 Sep 2019 | 600,000 | 751,306 |
D A Martin | 100,000 | 61.50p | 1 Oct 2014 - 30 Sep 2019 | 559,279 | 280,000 |
All options were granted under the Futura Medical plc Enterprise Management Incentive Scheme.
The main vesting condition of the options is that the Directors remain employed with the Company as at the date of exercise.
For any further information please contact:
Futura Medical plc |
|
James Barder, Chief Executive | Tel: +44 (0) 1483 685 670 |
|
|
mail to: james.barder@futuramedical.com | www.futuramedical.com |
|
|
Nomura Code Securities Limited |
|
Phil Walker / Giles Balleny | Tel:+44 (0) 20 7776 1200 |
|
|
For media enquiries please contact: |
|
|
|
Buchanan |
|
Mark Court / Fiona Henson / Sophie Cowles | Tel: +44 (0) 20 7466 5000 |
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com